BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 19, 2017
View Archived Issues
BioAxone BioSciences awarded funding to develop sd-rxRNA compound for spinal cord injury
Read More
Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation
Read More
Novel dual Axl/Mer inhibitors designed at Ono Pharmaceutical
Read More
First results of PATHWAY study on tezepelumab in severe asthma patients reported
Read More
Immunocore and Bill & Melinda Gates Foundation collaborate to develop TCR-based therapeutics
Read More
Pluristem Therapeutics' PLX-PAD given FDA fast track status for critical limb ischemia
Read More
Emcure Pharmaceuticals discovers novel IDO-1, TDO inhibitors
Read More
Novel interleukin-1 receptor-associated kinase 4 inhibitors identified at Bayer
Read More
Galapagos presents new sphingosine 1-phosphate receptor antagonists
Read More
New serine protease HTRA1 inhibitors disclosed by Roche
Read More
CSIR identifies novel aurone alkaloids for tuberculosis
Read More
DelMar Pharmaceuticals cleared by FDA to begin clinical studies of VAL-083
Read More
Pain Therapeutics receives NIH grants to support Alzheimer's and pain programs
Read More
EMA committee recommends approval of 10 mg rivaroxaban for extended prevention of VTE
Read More
Moderna Therapeutics reports new development candidates and pipeline progress
Read More
Innovate UK awards new funding to Cypralis to develop inhibitors of pancreatic fibrosis
Read More
NCI SBIR grant to support phase III study of SGX-301 in CTCL
Read More
Phase III MURANO study of venetoclax/rituximab combo in CLL meets primary endpoint
Read More
Dupilumab given FDA orphan drug status for eosinophilic esophagitis
Read More
Inovio Pharmaceuticals cleared to begin trial of MERS vaccine
Read More
New feline model of heart failure with preserved ejection fraction described
Read More
FDA approves Trelegy Ellipta for COPD
Read More
Cancer Prevention Pharmaceuticals's lead drug for FAP granted fast track status in U.S.
Read More
Autolus begins phase I/II studies of AUTO-3 for B-cell ALL and DLBCL
Read More
G3 Pharmaceuticals starts research and development program to pursue novel galectin-3 inhibitors
Read More
FDA accepts Camurus' NDA for CAM-2038 buprenorphine depots
Read More
Bristol-Myers Squibb describes discovery of phase I anti-PD-L1 candidate BMS-986189
Read More
FDA approves Xhance for treatment of nasal polyps
Read More
Arrowhead updates status of pipeline
Read More
BELLUS Health's BLU-5937 significantly reduces cough in preclinical models
Read More